Efficacy

"The data presented at the conference suggest that prifemilast has the potential to be a highly effective PDE4 inhibitor, delivering meaningfully greater efficacy than the standard of the class with once-daily dosing.

Edit

Strong Future supporters tout program successes while opponents criticize timeframe, efficacy

Summit Daily 09 Oct 2026

Another of Bacher’s concerns surrounds the efficacy of the programs ... He said evaluations of efficacy coming from a third party would be best because the organizations that receive Strong Future ...

Edit

Prifemilast Demonstrates Superior Efficacy vs. Apremilast in Newsoara’s Head-to-Head Phase 3 Psoriasis Trial; cAMPfield Advancing the Potential Best-in-Class Oral PDE4 Inhibitor in IBD (cAMPfield Therapeutics Inc)

Public Technologies 09 Oct 2026

The data presented at the conference suggest that prifemilast has the potential to be a highly effective PDE4 inhibitor, delivering meaningfully greater efficacy than the standard of the class with once-daily dosing.

Edit

PulseSight presents PST-611 Phase I new early clinical efficacy data at EURETINA, offering a potential ...

Nasdaq Globe Newswire 07 Oct 2026

PARIS, Oct ... .

Edit

Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the ...

Nasdaq Globe Newswire 07 Oct 2026

ATSN-201 demonstrated structural and functional benefit in Parts A and B, including microperimetry improvements exceeding the level the FDA has defined as supportive of potential approval ... .

Edit

MUVON Therapeutics Reports Positive 12-Month Phase 2 Follow-up Data Confirming Durable Efficacy of its First-in-Class ...

Nasdaq Globe Newswire 07 Oct 2026

SUI represents a high unmet medical need, affecting more than 150 million women worldwide, for which no approved therapy presently addresses the underlying cause ... .

Edit

Kairos Pharma Reports Positive, Statistically Significant Interim Efficacy Data from Phase 2 Trial of ENV-105 ...

The Milton Standard Journal 06 Oct 2026

LOS ANGELES--(BUSINESS WIRE)--Oct 6, 2026-- ....

Edit

Efficacy of a feed additive consisting of vermiculite for piglets and pigs for fattening (Regal B.V.) (EFSA - European Food Safety Authority)

Public Technologies 06 Oct 2026

). The text version of this document is not available ... Attachments Original document Permalink.

Edit

Safety and efficacy of a feed additive consisting of a tincture derived from the leaves of Urtica urens L. (dwarf nettle tincture) for use in all animal species (FEFANA asbl) (EFSA - European Food Safety Authority)

Public Technologies 06 Oct 2026

). The text version of this document is not available ... Attachments Original document Permalink.

Podcasts:

Latest News for: efficacy

Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE Attacks Published ...

Prifemilast Demonstrates Superior Efficacy vs. Apremilast in Newsoara's Head-to-Head Phase 3 Psoriasis Trial; cAMPfield Advancing ...

Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE

NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European ...

AHA Hypertension 2026: Efficacy and Safety of the Selective Aldosterone Synthase Inhibitor Lorundrostat in Moderate-to-Severe Apnea and Hypertension: Explore-OSA Randomized Crossover Trial (Mineralys Therapeutics Inc)

Safety and efficacy of feed additives consisting of tinctures derived from the roots or leaves and stems of Althaea officinalis L.: Marsh mallow root tincture for use in all animal species and marsh mallow leaf tincture for use in horses and dogs (FEFANA asbl) (EFSA - European Food Safety Authority)

Prifemilast Demonstrates Superior Efficacy vs. Apremilast in Newsoara's Head-to-Head Phase 3 Psoriasis Trial; cAMPfield Advancing the Potential Best-in-Class Oral PDE4 Inhibitor in IBD

Strong Future supporters tout program successes while opponents criticize timeframe, efficacy

Prifemilast Demonstrates Superior Efficacy vs. Apremilast in Newsoara’s Head-to-Head Phase 3 Psoriasis Trial; cAMPfield Advancing the Potential Best-in-Class Oral PDE4 Inhibitor in IBD (cAMPfield Therapeutics Inc)

PulseSight presents PST-611 Phase I new early clinical efficacy data at EURETINA, offering a potential ...

Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the ...

MUVON Therapeutics Reports Positive 12-Month Phase 2 Follow-up Data Confirming Durable Efficacy of its First-in-Class ...

Kairos Pharma Reports Positive, Statistically Significant Interim Efficacy Data from Phase 2 Trial of ENV-105 ...

Efficacy of a feed additive consisting of vermiculite for piglets and pigs for fattening (Regal B.V.) (EFSA - European Food Safety Authority)

Safety and efficacy of a feed additive consisting of a tincture derived from the leaves of Urtica urens L. (dwarf nettle tincture) for use in all animal species (FEFANA asbl) (EFSA - European Food Safety Authority)

Article Search

EXPLORE WN.com